Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

NCT02154854 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

104

Enrollment

OTHER

Sponsor class

Conditions

De Novo Transplant Disease

Interventions

DRUG: Tacrolimus targeted half-dose
DRUG: Tacrolimus targeted plain dose

Sponsor

University Hospital, Tours

Collaborators

[object Object]